Switching to amisulpride monotherapy for treatment-resistant schizophrenia

European Psychiatry : the Journal of the Association of European Psychiatrists
V P KontaxakisC R Soldatos

Abstract

The objective of this study was to assess switching to amisulpride (AMS) in treatment-resistant schizophrenia. Seven male subjects were switched to AMS and followed for 8 weeks. PANSS scores improved from 123 to 66 over this period. We conclude that AMS is of interest in the treatment of refractory schizophrenia.

References

Aug 1, 1990·Hospital & Community Psychiatry·H Y MeltzerL F Ramirez
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Nov 5, 1999·The Journal of Clinical Psychiatry·A L MillerS P Shon
Feb 5, 2002·Schizophrenia Bulletin·P BuckleyJ Csernansky
Dec 5, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel SechterUNKNOWN Amisulpride Study Group
Jun 11, 2003·Archives of General Psychiatry·John M DavisIra D Glick
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hans-Jürgen Möller
Jan 2, 2004·The American Journal of Psychiatry·Dennis S Charney
Feb 19, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·Mathias ZinkJohannes Thome
Feb 20, 2004·The International Journal of Neuropsychopharmacology·Ann M Mortimer
Apr 13, 2004·International Clinical Psychopharmacology·Ann MortimerUNKNOWN SOLIANOL Sudy Group
May 4, 2004·The American Journal of Psychiatry·Marcus W AgelinkIsmail Ak
Feb 16, 2005·Clinical Neuropharmacology·Vassilis P KontaxakisGeorge N Christodoulou
Mar 30, 2005·Clinical Neuropharmacology·Vladimir LernerChanoch Miodownik
Jun 30, 2005·Journal of Psychiatric Practice·Leslie CitromeJan Volavka

❮ Previous
Next ❯

Citations

Jun 27, 2009·Neuropsychiatric Disease and Treatment·Ann M Mortimer
Jul 4, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·Laurence Borras, Philippe Huguelet
Jul 9, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Dattatreya Mendhekar, Deep Lohia
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Mar 1, 2008·Journal of Psychopharmacology·U E LangS Malte Tugtekin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here